| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.094 | 0.7 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.046 | 0.7 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |